SHELTON, CT / ACCESS Newswire / October 20, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), announced that its clinical lead drug NV-387 has shown strong ...
Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 10, 2026 / NanoViricides, Inc., a publicly traded company (NYSE ...
SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum ...
Beyond the luxury resorts and crystal waters, the South Pacific nation of Fiji is currently grappling with the world’s most aggressive HIV outbreak. This public health crisis is tied directly […] ...
This vaccine is used to help prevent infection by the respiratory syncytial virus (RSV). It may also be used during the third trimester of pregnancy to help prevent RSV in the newborn baby. RSV can ...
Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...
Spironolactone, a drug used to manage salt absorption and fluid retention in heart failure patients, also plays a role in inhibiting function of a protein essential to Epstein-Barr virus, a member of ...
FORT DETRICK, Md. -- The first strong evidence that medicine will eventually defeat the SARS virus has come to light in recent days at the Army's biodefense labs, where the world's most intensive and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results